Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Accolade, Inc.ACCD · Entity 80959 | Fomer Director | January 22, 2021 | January 26, 2021 |
| Genpact LTDG · Entity 3760 | Director | April 23, 2026 | April 27, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Accolade, Inc.
Report date January 22, 2021 · Filed January 26, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee footnotes | 188,766 |
Last balance in matching sequence
After 2021-01-25 transaction · row 12
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
12 source rowsRow 1 · 2021-01-22 · Other · Disposed 341,153 · Balance 3,289,843 F1: On January 22, 2021, 341,153 shares of the common stock of Accolade, Inc. (the "Common Stock") held of record by Carrick Capital Associates Fund, L.P. ("CCAF") were distributed to the fund's respective partners for no consideration. CCAF no longer holds any shares of Common Stock. On the same date, 3,401 of CCAF's shares of Common Stock were transferred to Carrick Management Partners, LLC ("CMP"), CCAF's general partner. F9: CMP is the general partner of each of CCAF, CCFF and CCP (the "CMP Group"). CMPII is the general partner of each of CIF and CIFII (the "CMPII Group"). CMP and CMPII may be deemed to have voting, investment and dispositive power with respect to the securities held by the CMP Group and the CMPII Group, respectively. The reporting person is a managing member of both CMP and CMPII. Thus, the reporting person may be deemed to share voting, investment and dispositive power with respect to the shares of Common Stock held by CMP and the CMP Group and CMPII and the CMPII Group. F10: Additionally, the reporting person, as the trustee of the Trust, has the sole voting and disposition power in connection with the Common Stock held of record by the Trust. The reporting person disclaims beneficial ownership of the securities discussed herein and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interests therein. Row 2 · 2021-01-22 · Other · Acquired 3,401 · Balance 3,293,244 F1: On January 22, 2021, 341,153 shares of the common stock of Accolade, Inc. (the "Common Stock") held of record by Carrick Capital Associates Fund, L.P. ("CCAF") were distributed to the fund's respective partners for no consideration. CCAF no longer holds any shares of Common Stock. On the same date, 3,401 of CCAF's shares of Common Stock were transferred to Carrick Management Partners, LLC ("CMP"), CCAF's general partner. F9: CMP is the general partner of each of CCAF, CCFF and CCP (the "CMP Group"). CMPII is the general partner of each of CIF and CIFII (the "CMPII Group"). CMP and CMPII may be deemed to have voting, investment and dispositive power with respect to the securities held by the CMP Group and the CMPII Group, respectively. The reporting person is a managing member of both CMP and CMPII. Thus, the reporting person may be deemed to share voting, investment and dispositive power with respect to the shares of Common Stock held by CMP and the CMP Group and CMPII and the CMPII Group. F10: Additionally, the reporting person, as the trustee of the Trust, has the sole voting and disposition power in connection with the Common Stock held of record by the Trust. The reporting person disclaims beneficial ownership of the securities discussed herein and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interests therein. Row 3 · 2021-01-22 · Other · Disposed 6,682 · Balance 3,286,562 F2: On January 22, 2021, 6,682 shares of the Common Stock held of record by Carrick Capital Founders Fund, L.P. ("CCFF") were distributed to the fund's respective partners for no consideration. CCFF continued to hold 109,878 shares of Common Stock. F9: CMP is the general partner of each of CCAF, CCFF and CCP (the "CMP Group"). CMPII is the general partner of each of CIF and CIFII (the "CMPII Group"). CMP and CMPII may be deemed to have voting, investment and dispositive power with respect to the securities held by the CMP Group and the CMPII Group, respectively. The reporting person is a managing member of both CMP and CMPII. Thus, the reporting person may be deemed to share voting, investment and dispositive power with respect to the shares of Common Stock held by CMP and the CMP Group and CMPII and the CMPII Group. F10: Additionally, the reporting person, as the trustee of the Trust, has the sole voting and disposition power in connection with the Common Stock held of record by the Trust. The reporting person disclaims beneficial ownership of the securities discussed herein and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interests therein. Row 4 · 2021-01-22 · Other · Disposed 2,075,349 · Balance 1,211,213 F3: On January 22, 2021, 2,075,349 shares of the Common Stock held of record by Carrick Capital Partners, L.P. ("CCP") were distributed to the fund's respective partners, on a pro rata basis, for no consideration. CCP no longer holds any shares of Common Stock. On the same date, 20,491 of CCP's shares of Common Stock were transferred to CMP, CCP's general partner. F9: CMP is the general partner of each of CCAF, CCFF and CCP (the "CMP Group"). CMPII is the general partner of each of CIF and CIFII (the "CMPII Group"). CMP and CMPII may be deemed to have voting, investment and dispositive power with respect to the securities held by the CMP Group and the CMPII Group, respectively. The reporting person is a managing member of both CMP and CMPII. Thus, the reporting person may be deemed to share voting, investment and dispositive power with respect to the shares of Common Stock held by CMP and the CMP Group and CMPII and the CMPII Group. F10: Additionally, the reporting person, as the trustee of the Trust, has the sole voting and disposition power in connection with the Common Stock held of record by the Trust. The reporting person disclaims beneficial ownership of the securities discussed herein and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interests therein. Row 5 · 2021-01-22 · Other · Acquired 20,491 · Balance 1,231,704 F3: On January 22, 2021, 2,075,349 shares of the Common Stock held of record by Carrick Capital Partners, L.P. ("CCP") were distributed to the fund's respective partners, on a pro rata basis, for no consideration. CCP no longer holds any shares of Common Stock. On the same date, 20,491 of CCP's shares of Common Stock were transferred to CMP, CCP's general partner. F9: CMP is the general partner of each of CCAF, CCFF and CCP (the "CMP Group"). CMPII is the general partner of each of CIF and CIFII (the "CMPII Group"). CMP and CMPII may be deemed to have voting, investment and dispositive power with respect to the securities held by the CMP Group and the CMPII Group, respectively. The reporting person is a managing member of both CMP and CMPII. Thus, the reporting person may be deemed to share voting, investment and dispositive power with respect to the shares of Common Stock held by CMP and the CMP Group and CMPII and the CMPII Group. F10: Additionally, the reporting person, as the trustee of the Trust, has the sole voting and disposition power in connection with the Common Stock held of record by the Trust. The reporting person disclaims beneficial ownership of the securities discussed herein and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interests therein. Row 6 · 2021-01-22 · Other · Disposed 487,608 · Balance 744,096 F4: On January 22, 2021, 487,608 shares of the Common Stock held of record by Carrick Capital Partners II Co-Investment Fund, L.P. ("CIF") were distributed to the fund's partner for no consideration. CIF no longer holds any shares of Common Stock. F9: CMP is the general partner of each of CCAF, CCFF and CCP (the "CMP Group"). CMPII is the general partner of each of CIF and CIFII (the "CMPII Group"). CMP and CMPII may be deemed to have voting, investment and dispositive power with respect to the securities held by the CMP Group and the CMPII Group, respectively. The reporting person is a managing member of both CMP and CMPII. Thus, the reporting person may be deemed to share voting, investment and dispositive power with respect to the shares of Common Stock held by CMP and the CMP Group and CMPII and the CMPII Group. F10: Additionally, the reporting person, as the trustee of the Trust, has the sole voting and disposition power in connection with the Common Stock held of record by the Trust. The reporting person disclaims beneficial ownership of the securities discussed herein and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interests therein. Row 7 · 2021-01-22 · Other · Disposed 487,608 · Balance 256,488 F5: On January 22 ,2021, 487,608 shares of the Common Stock held of record by Carrick Capital Partners II Co-Investment Fund II, L.P. ("CIFII") were distributed to the fund's partner for no consideration (the forgoing transactions discussed in footnotes (1)-(5) constituting the "Distribution"). CIFII no longer holds any shares of Common Stock. F9: CMP is the general partner of each of CCAF, CCFF and CCP (the "CMP Group"). CMPII is the general partner of each of CIF and CIFII (the "CMPII Group"). CMP and CMPII may be deemed to have voting, investment and dispositive power with respect to the securities held by the CMP Group and the CMPII Group, respectively. The reporting person is a managing member of both CMP and CMPII. Thus, the reporting person may be deemed to share voting, investment and dispositive power with respect to the shares of Common Stock held by CMP and the CMP Group and CMPII and the CMPII Group. F10: Additionally, the reporting person, as the trustee of the Trust, has the sole voting and disposition power in connection with the Common Stock held of record by the Trust. The reporting person disclaims beneficial ownership of the securities discussed herein and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interests therein. Row 8 · 2021-01-22 · Other · Disposed 1,674 · Balance 254,814 F6: On January 22, 2021 CMP further distributed 1,674 of the shares of the Common Stock that it received from the Distribution to its non-managing member for no consideration. CMP continued to hold 22,218 shares of Common Stock. F9: CMP is the general partner of each of CCAF, CCFF and CCP (the "CMP Group"). CMPII is the general partner of each of CIF and CIFII (the "CMPII Group"). CMP and CMPII may be deemed to have voting, investment and dispositive power with respect to the securities held by the CMP Group and the CMPII Group, respectively. The reporting person is a managing member of both CMP and CMPII. Thus, the reporting person may be deemed to share voting, investment and dispositive power with respect to the shares of Common Stock held by CMP and the CMP Group and CMPII and the CMPII Group. F10: Additionally, the reporting person, as the trustee of the Trust, has the sole voting and disposition power in connection with the Common Stock held of record by the Trust. The reporting person disclaims beneficial ownership of the securities discussed herein and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interests therein. Row 9 · 2021-01-25 · Other · Disposed 109,878 · Balance 144,936 F7: On January 25, 2021, 109,878 shares of the Common Stock held of record by CCFF were distributed to certain of the fund's partners, on a pro rata basis, for no consideration. CCFF no longer holds any shares of Common Stock. On the same date, 54,939 of CCFF's shares of Common Stock were transferred to the James C. Madden, V. Living Trust (the "Trust"), of which the reporting person is the trustee. F9: CMP is the general partner of each of CCAF, CCFF and CCP (the "CMP Group"). CMPII is the general partner of each of CIF and CIFII (the "CMPII Group"). CMP and CMPII may be deemed to have voting, investment and dispositive power with respect to the securities held by the CMP Group and the CMPII Group, respectively. The reporting person is a managing member of both CMP and CMPII. Thus, the reporting person may be deemed to share voting, investment and dispositive power with respect to the shares of Common Stock held by CMP and the CMP Group and CMPII and the CMPII Group. F10: Additionally, the reporting person, as the trustee of the Trust, has the sole voting and disposition power in connection with the Common Stock held of record by the Trust. The reporting person disclaims beneficial ownership of the securities discussed herein and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interests therein. Row 10 · 2021-01-25 · Other · Acquired 54,939 · Balance 199,875 F7: On January 25, 2021, 109,878 shares of the Common Stock held of record by CCFF were distributed to certain of the fund's partners, on a pro rata basis, for no consideration. CCFF no longer holds any shares of Common Stock. On the same date, 54,939 of CCFF's shares of Common Stock were transferred to the James C. Madden, V. Living Trust (the "Trust"), of which the reporting person is the trustee. F9: CMP is the general partner of each of CCAF, CCFF and CCP (the "CMP Group"). CMPII is the general partner of each of CIF and CIFII (the "CMPII Group"). CMP and CMPII may be deemed to have voting, investment and dispositive power with respect to the securities held by the CMP Group and the CMPII Group, respectively. The reporting person is a managing member of both CMP and CMPII. Thus, the reporting person may be deemed to share voting, investment and dispositive power with respect to the shares of Common Stock held by CMP and the CMP Group and CMPII and the CMPII Group. F10: Additionally, the reporting person, as the trustee of the Trust, has the sole voting and disposition power in connection with the Common Stock held of record by the Trust. The reporting person disclaims beneficial ownership of the securities discussed herein and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interests therein. Row 11 · 2021-01-25 · Other · Disposed 22,218 · Balance 177,657 F8: On January 25, 2021, 22,218 shares of the Common Stock held of record by CMP were distributed to certain of its members, on a pro rata basis, for no consideration. CMP no longer holds any shares of Common Stock. On the same date, 11,109 of CMP's shares of Common Stock were transferred to the Trust. F9: CMP is the general partner of each of CCAF, CCFF and CCP (the "CMP Group"). CMPII is the general partner of each of CIF and CIFII (the "CMPII Group"). CMP and CMPII may be deemed to have voting, investment and dispositive power with respect to the securities held by the CMP Group and the CMPII Group, respectively. The reporting person is a managing member of both CMP and CMPII. Thus, the reporting person may be deemed to share voting, investment and dispositive power with respect to the shares of Common Stock held by CMP and the CMP Group and CMPII and the CMPII Group. F10: Additionally, the reporting person, as the trustee of the Trust, has the sole voting and disposition power in connection with the Common Stock held of record by the Trust. The reporting person disclaims beneficial ownership of the securities discussed herein and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interests therein. Row 12 · 2021-01-25 · Other · Acquired 11,109 · Balance 188,766 F8: On January 25, 2021, 22,218 shares of the Common Stock held of record by CMP were distributed to certain of its members, on a pro rata basis, for no consideration. CMP no longer holds any shares of Common Stock. On the same date, 11,109 of CMP's shares of Common Stock were transferred to the Trust. F9: CMP is the general partner of each of CCAF, CCFF and CCP (the "CMP Group"). CMPII is the general partner of each of CIF and CIFII (the "CMPII Group"). CMP and CMPII may be deemed to have voting, investment and dispositive power with respect to the securities held by the CMP Group and the CMPII Group, respectively. The reporting person is a managing member of both CMP and CMPII. Thus, the reporting person may be deemed to share voting, investment and dispositive power with respect to the shares of Common Stock held by CMP and the CMP Group and CMPII and the CMPII Group. F10: Additionally, the reporting person, as the trustee of the Trust, has the sole voting and disposition power in connection with the Common Stock held of record by the Trust. The reporting person disclaims beneficial ownership of the securities discussed herein and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interests therein. |
Filing footnotes · ownership attribution and instrument terms
F1: On January 22, 2021, 341,153 shares of the common stock of Accolade, Inc. (the "Common Stock") held of record by Carrick Capital Associates Fund, L.P. ("CCAF") were distributed to the fund's respective partners for no consideration. CCAF no longer holds any shares of Common Stock. On the same date, 3,401 of CCAF's shares of Common Stock were transferred to Carrick Management Partners, LLC ("CMP"), CCAF's general partner.
F2: On January 22, 2021, 6,682 shares of the Common Stock held of record by Carrick Capital Founders Fund, L.P. ("CCFF") were distributed to the fund's respective partners for no consideration. CCFF continued to hold 109,878 shares of Common Stock.
F3: On January 22, 2021, 2,075,349 shares of the Common Stock held of record by Carrick Capital Partners, L.P. ("CCP") were distributed to the fund's respective partners, on a pro rata basis, for no consideration. CCP no longer holds any shares of Common Stock. On the same date, 20,491 of CCP's shares of Common Stock were transferred to CMP, CCP's general partner.
F4: On January 22, 2021, 487,608 shares of the Common Stock held of record by Carrick Capital Partners II Co-Investment Fund, L.P. ("CIF") were distributed to the fund's partner for no consideration. CIF no longer holds any shares of Common Stock.
F5: On January 22 ,2021, 487,608 shares of the Common Stock held of record by Carrick Capital Partners II Co-Investment Fund II, L.P. ("CIFII") were distributed to the fund's partner for no consideration (the forgoing transactions discussed in footnotes (1)-(5) constituting the "Distribution"). CIFII no longer holds any shares of Common Stock.
F6: On January 22, 2021 CMP further distributed 1,674 of the shares of the Common Stock that it received from the Distribution to its non-managing member for no consideration. CMP continued to hold 22,218 shares of Common Stock.
F7: On January 25, 2021, 109,878 shares of the Common Stock held of record by CCFF were distributed to certain of the fund's partners, on a pro rata basis, for no consideration. CCFF no longer holds any shares of Common Stock. On the same date, 54,939 of CCFF's shares of Common Stock were transferred to the James C. Madden, V. Living Trust (the "Trust"), of which the reporting person is the trustee.
F8: On January 25, 2021, 22,218 shares of the Common Stock held of record by CMP were distributed to certain of its members, on a pro rata basis, for no consideration. CMP no longer holds any shares of Common Stock. On the same date, 11,109 of CMP's shares of Common Stock were transferred to the Trust.
F9: CMP is the general partner of each of CCAF, CCFF and CCP (the "CMP Group"). CMPII is the general partner of each of CIF and CIFII (the "CMPII Group"). CMP and CMPII may be deemed to have voting, investment and dispositive power with respect to the securities held by the CMP Group and the CMPII Group, respectively. The reporting person is a managing member of both CMP and CMPII. Thus, the reporting person may be deemed to share voting, investment and dispositive power with respect to the shares of Common Stock held by CMP and the CMP Group and CMPII and the CMPII Group.
F10: Additionally, the reporting person, as the trustee of the Trust, has the sole voting and disposition power in connection with the Common Stock held of record by the Trust. The reporting person disclaims beneficial ownership of the securities discussed herein and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interests therein.
Genpact LTD
Report date April 23, 2026 · Filed April 27, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | Direct | 73,067 |
Reported balance
After 2026-04-23 transaction · row 1
1 source rowRow 1 · 2026-04-23 · Grant · Acquired 9,999 · Balance 73,067 F1: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2026 and will be settled in common shares on December 31, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2026 and will be settled in common shares on December 31, 2027.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 23, 2026 Filed Apr 27, 2026 20:23 UTC | Genpact LTD G · Entity 3760 | GrantCommon Shares | 9,999 | $0.00 | $0.00 |
DisclosureSEC source: 0001408228-26-000002 · wk-form4_1777321413.xml · nonDerivative · entry 1 Madden James C. · CIK 0001408228 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,067 F1 · shares: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2026 and will be settled in common shares on December 31, 2027. Read SEC document |
| May 22, 2025 Filed May 27, 2025 20:59 UTC | Genpact LTD G · Entity 3760 | GrantCommon Shares | 7,582 | $0.00 | $0.00 |
DisclosureSEC source: 0001398659-25-000071 · wk-form4_1748379570.xml · nonDerivative · entry 1 Madden James C. · CIK 0001408228 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,068 F1 · shares: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2025 and will be settled in common shares on December 31, 2026. Read SEC document |
| May 02, 2024 Filed May 6, 2024 20:22 UTC | Genpact LTD G · Entity 3760 | GrantCommon Shares | 10,539 | $0.00 | $0.00 |
DisclosureSEC source: 0001398659-24-000067 · wk-form4_1715026930.xml · nonDerivative · entry 1 Madden James C. · CIK 0001408228 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,486 F1 · shares: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2024 and will be settled in common shares on December 31, 2025. Read SEC document |
| May 16, 2023 Filed May 18, 2023 12:00 UTC | Genpact LTD G · Entity 3760 | PurchaseCommon Shares | 500 | $36.60 | $18,299.60 |
DisclosureSEC source: 0001140361-23-025388 · form4.xml · nonDerivative · entry 2 Madden James C. · CIK 0001408228 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,947 Read SEC document |
| May 16, 2023 Filed May 18, 2023 12:00 UTC | Genpact LTD G · Entity 3760 | PurchaseCommon Shares | 2,000 | $36.93 | $73,858.20 |
DisclosureSEC source: 0001140361-23-025388 · form4.xml · nonDerivative · entry 1 Madden James C. · CIK 0001408228 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,447 F1 · price: The price in Column 4 is a weighted average price. The actual purchase prices for these transactions ranged from $36.54 to $37.00. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range. Read SEC document |
| May 04, 2023 Filed May 8, 2023 20:12 UTC | Genpact LTD G · Entity 3760 | GrantCommon Shares | 7,865 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-023500 · form4.xml · nonDerivative · entry 1 Madden James C. · CIK 0001408228 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,447 F1 · shares: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2023 and will be settled in common shares on December 31, 2024. Read SEC document |
| May 19, 2022 Filed May 23, 2022 20:19 UTC | Genpact LTD G · Entity 3760 | GrantCommon Shares | 7,726 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-011512 · doc1.xml · nonDerivative · entry 1 Madden James C. · CIK 0001408228 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,582 F1 · shares: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2022 and will be settled in common shares on December 31, 2023. Read SEC document |
| May 05, 2021 Filed May 7, 2021 20:11 UTC | Genpact LTD G · Entity 3760 | GrantCommon Shares | 6,252 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-009306 · doc1.xml · nonDerivative · entry 1 Madden James C. · CIK 0001408228 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,856 F1 · shares: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2021 and will be settled in common shares on December 31, 2022. Read SEC document |
| January 25, 2021 Filed Jan 26, 2021 18:44 UTC | Accolade, Inc. ACCD · Entity 80959 | OtherCommon Stock | 11,109 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-21-000070 · form4.xml · nonDerivative · entry 12 Madden James C. · CIK 0001408228 · Fomer Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 188,766 F8 · shares: On January 25, 2021, 22,218 shares of the Common Stock held of record by CMP were distributed to certain of its members, on a pro rata basis, for no consideration. CMP no longer holds any shares of Common Stock. On the same date, 11,109 of CMP's shares of Common Stock were transferred to the Trust. F8 · price: On January 25, 2021, 22,218 shares of the Common Stock held of record by CMP were distributed to certain of its members, on a pro rata basis, for no consideration. CMP no longer holds any shares of Common Stock. On the same date, 11,109 of CMP's shares of Common Stock were transferred to the Trust. F9 · ownership.nature: CMP is the general partner of each of CCAF, CCFF and CCP (the "CMP Group"). CMPII is the general partner of each of CIF and CIFII (the "CMPII Group"). CMP and CMPII may be deemed to have voting, investment and dispositive power with respect to the securities held by the CMP Group and the CMPII Group, respectively. The reporting person is a managing member of both CMP and CMPII. Thus, the reporting person may be deemed to share voting, investment and dispositive power with respect to the shares of Common Stock held by CMP and the CMP Group and CMPII and the CMPII Group. F10 · ownership.nature: Additionally, the reporting person, as the trustee of the Trust, has the sole voting and disposition power in connection with the Common Stock held of record by the Trust. The reporting person disclaims beneficial ownership of the securities discussed herein and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interests therein. Read SEC document |
| January 25, 2021 Filed Jan 26, 2021 18:44 UTC | Accolade, Inc. ACCD · Entity 80959 | OtherCommon Stock | 22,218 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-21-000070 · form4.xml · nonDerivative · entry 11 Madden James C. · CIK 0001408228 · Fomer Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 177,657 F8 · shares: On January 25, 2021, 22,218 shares of the Common Stock held of record by CMP were distributed to certain of its members, on a pro rata basis, for no consideration. CMP no longer holds any shares of Common Stock. On the same date, 11,109 of CMP's shares of Common Stock were transferred to the Trust. F8 · price: On January 25, 2021, 22,218 shares of the Common Stock held of record by CMP were distributed to certain of its members, on a pro rata basis, for no consideration. CMP no longer holds any shares of Common Stock. On the same date, 11,109 of CMP's shares of Common Stock were transferred to the Trust. F9 · ownership.nature: CMP is the general partner of each of CCAF, CCFF and CCP (the "CMP Group"). CMPII is the general partner of each of CIF and CIFII (the "CMPII Group"). CMP and CMPII may be deemed to have voting, investment and dispositive power with respect to the securities held by the CMP Group and the CMPII Group, respectively. The reporting person is a managing member of both CMP and CMPII. Thus, the reporting person may be deemed to share voting, investment and dispositive power with respect to the shares of Common Stock held by CMP and the CMP Group and CMPII and the CMPII Group. F10 · ownership.nature: Additionally, the reporting person, as the trustee of the Trust, has the sole voting and disposition power in connection with the Common Stock held of record by the Trust. The reporting person disclaims beneficial ownership of the securities discussed herein and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interests therein. Read SEC document |
| January 25, 2021 Filed Jan 26, 2021 18:44 UTC | Accolade, Inc. ACCD · Entity 80959 | OtherCommon Stock | 54,939 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-21-000070 · form4.xml · nonDerivative · entry 10 Madden James C. · CIK 0001408228 · Fomer Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 199,875 F7 · shares: On January 25, 2021, 109,878 shares of the Common Stock held of record by CCFF were distributed to certain of the fund's partners, on a pro rata basis, for no consideration. CCFF no longer holds any shares of Common Stock. On the same date, 54,939 of CCFF's shares of Common Stock were transferred to the James C. Madden, V. Living Trust (the "Trust"), of which the reporting person is the trustee. F7 · price: On January 25, 2021, 109,878 shares of the Common Stock held of record by CCFF were distributed to certain of the fund's partners, on a pro rata basis, for no consideration. CCFF no longer holds any shares of Common Stock. On the same date, 54,939 of CCFF's shares of Common Stock were transferred to the James C. Madden, V. Living Trust (the "Trust"), of which the reporting person is the trustee. F9 · ownership.nature: CMP is the general partner of each of CCAF, CCFF and CCP (the "CMP Group"). CMPII is the general partner of each of CIF and CIFII (the "CMPII Group"). CMP and CMPII may be deemed to have voting, investment and dispositive power with respect to the securities held by the CMP Group and the CMPII Group, respectively. The reporting person is a managing member of both CMP and CMPII. Thus, the reporting person may be deemed to share voting, investment and dispositive power with respect to the shares of Common Stock held by CMP and the CMP Group and CMPII and the CMPII Group. F10 · ownership.nature: Additionally, the reporting person, as the trustee of the Trust, has the sole voting and disposition power in connection with the Common Stock held of record by the Trust. The reporting person disclaims beneficial ownership of the securities discussed herein and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interests therein. Read SEC document |
| January 25, 2021 Filed Jan 26, 2021 18:44 UTC | Accolade, Inc. ACCD · Entity 80959 | OtherCommon Stock | 109,878 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-21-000070 · form4.xml · nonDerivative · entry 9 Madden James C. · CIK 0001408228 · Fomer Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 144,936 F7 · shares: On January 25, 2021, 109,878 shares of the Common Stock held of record by CCFF were distributed to certain of the fund's partners, on a pro rata basis, for no consideration. CCFF no longer holds any shares of Common Stock. On the same date, 54,939 of CCFF's shares of Common Stock were transferred to the James C. Madden, V. Living Trust (the "Trust"), of which the reporting person is the trustee. F7 · price: On January 25, 2021, 109,878 shares of the Common Stock held of record by CCFF were distributed to certain of the fund's partners, on a pro rata basis, for no consideration. CCFF no longer holds any shares of Common Stock. On the same date, 54,939 of CCFF's shares of Common Stock were transferred to the James C. Madden, V. Living Trust (the "Trust"), of which the reporting person is the trustee. F9 · ownership.nature: CMP is the general partner of each of CCAF, CCFF and CCP (the "CMP Group"). CMPII is the general partner of each of CIF and CIFII (the "CMPII Group"). CMP and CMPII may be deemed to have voting, investment and dispositive power with respect to the securities held by the CMP Group and the CMPII Group, respectively. The reporting person is a managing member of both CMP and CMPII. Thus, the reporting person may be deemed to share voting, investment and dispositive power with respect to the shares of Common Stock held by CMP and the CMP Group and CMPII and the CMPII Group. F10 · ownership.nature: Additionally, the reporting person, as the trustee of the Trust, has the sole voting and disposition power in connection with the Common Stock held of record by the Trust. The reporting person disclaims beneficial ownership of the securities discussed herein and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interests therein. Read SEC document |
| January 22, 2021 Filed Jan 26, 2021 18:44 UTC | Accolade, Inc. ACCD · Entity 80959 | OtherCommon Stock | 1,674 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-21-000070 · form4.xml · nonDerivative · entry 8 Madden James C. · CIK 0001408228 · Fomer Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 254,814 F6 · shares: On January 22, 2021 CMP further distributed 1,674 of the shares of the Common Stock that it received from the Distribution to its non-managing member for no consideration. CMP continued to hold 22,218 shares of Common Stock. F6 · price: On January 22, 2021 CMP further distributed 1,674 of the shares of the Common Stock that it received from the Distribution to its non-managing member for no consideration. CMP continued to hold 22,218 shares of Common Stock. F9 · ownership.nature: CMP is the general partner of each of CCAF, CCFF and CCP (the "CMP Group"). CMPII is the general partner of each of CIF and CIFII (the "CMPII Group"). CMP and CMPII may be deemed to have voting, investment and dispositive power with respect to the securities held by the CMP Group and the CMPII Group, respectively. The reporting person is a managing member of both CMP and CMPII. Thus, the reporting person may be deemed to share voting, investment and dispositive power with respect to the shares of Common Stock held by CMP and the CMP Group and CMPII and the CMPII Group. F10 · ownership.nature: Additionally, the reporting person, as the trustee of the Trust, has the sole voting and disposition power in connection with the Common Stock held of record by the Trust. The reporting person disclaims beneficial ownership of the securities discussed herein and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interests therein. Read SEC document |
| January 22, 2021 Filed Jan 26, 2021 18:44 UTC | Accolade, Inc. ACCD · Entity 80959 | OtherCommon Stock | 487,608 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-21-000070 · form4.xml · nonDerivative · entry 7 Madden James C. · CIK 0001408228 · Fomer Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 256,488 F5 · shares: On January 22 ,2021, 487,608 shares of the Common Stock held of record by Carrick Capital Partners II Co-Investment Fund II, L.P. ("CIFII") were distributed to the fund's partner for no consideration (the forgoing transactions discussed in footnotes (1)-(5) constituting the "Distribution"). CIFII no longer holds any shares of Common Stock. F5 · price: On January 22 ,2021, 487,608 shares of the Common Stock held of record by Carrick Capital Partners II Co-Investment Fund II, L.P. ("CIFII") were distributed to the fund's partner for no consideration (the forgoing transactions discussed in footnotes (1)-(5) constituting the "Distribution"). CIFII no longer holds any shares of Common Stock. F9 · ownership.nature: CMP is the general partner of each of CCAF, CCFF and CCP (the "CMP Group"). CMPII is the general partner of each of CIF and CIFII (the "CMPII Group"). CMP and CMPII may be deemed to have voting, investment and dispositive power with respect to the securities held by the CMP Group and the CMPII Group, respectively. The reporting person is a managing member of both CMP and CMPII. Thus, the reporting person may be deemed to share voting, investment and dispositive power with respect to the shares of Common Stock held by CMP and the CMP Group and CMPII and the CMPII Group. F10 · ownership.nature: Additionally, the reporting person, as the trustee of the Trust, has the sole voting and disposition power in connection with the Common Stock held of record by the Trust. The reporting person disclaims beneficial ownership of the securities discussed herein and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interests therein. Read SEC document |
| January 22, 2021 Filed Jan 26, 2021 18:44 UTC | Accolade, Inc. ACCD · Entity 80959 | OtherCommon Stock | 487,608 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-21-000070 · form4.xml · nonDerivative · entry 6 Madden James C. · CIK 0001408228 · Fomer Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 744,096 F4 · shares: On January 22, 2021, 487,608 shares of the Common Stock held of record by Carrick Capital Partners II Co-Investment Fund, L.P. ("CIF") were distributed to the fund's partner for no consideration. CIF no longer holds any shares of Common Stock. F4 · price: On January 22, 2021, 487,608 shares of the Common Stock held of record by Carrick Capital Partners II Co-Investment Fund, L.P. ("CIF") were distributed to the fund's partner for no consideration. CIF no longer holds any shares of Common Stock. F9 · ownership.nature: CMP is the general partner of each of CCAF, CCFF and CCP (the "CMP Group"). CMPII is the general partner of each of CIF and CIFII (the "CMPII Group"). CMP and CMPII may be deemed to have voting, investment and dispositive power with respect to the securities held by the CMP Group and the CMPII Group, respectively. The reporting person is a managing member of both CMP and CMPII. Thus, the reporting person may be deemed to share voting, investment and dispositive power with respect to the shares of Common Stock held by CMP and the CMP Group and CMPII and the CMPII Group. F10 · ownership.nature: Additionally, the reporting person, as the trustee of the Trust, has the sole voting and disposition power in connection with the Common Stock held of record by the Trust. The reporting person disclaims beneficial ownership of the securities discussed herein and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interests therein. Read SEC document |
| January 22, 2021 Filed Jan 26, 2021 18:44 UTC | Accolade, Inc. ACCD · Entity 80959 | OtherCommon Stock | 20,491 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-21-000070 · form4.xml · nonDerivative · entry 5 Madden James C. · CIK 0001408228 · Fomer Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,231,704 F3 · shares: On January 22, 2021, 2,075,349 shares of the Common Stock held of record by Carrick Capital Partners, L.P. ("CCP") were distributed to the fund's respective partners, on a pro rata basis, for no consideration. CCP no longer holds any shares of Common Stock. On the same date, 20,491 of CCP's shares of Common Stock were transferred to CMP, CCP's general partner. F3 · price: On January 22, 2021, 2,075,349 shares of the Common Stock held of record by Carrick Capital Partners, L.P. ("CCP") were distributed to the fund's respective partners, on a pro rata basis, for no consideration. CCP no longer holds any shares of Common Stock. On the same date, 20,491 of CCP's shares of Common Stock were transferred to CMP, CCP's general partner. F9 · ownership.nature: CMP is the general partner of each of CCAF, CCFF and CCP (the "CMP Group"). CMPII is the general partner of each of CIF and CIFII (the "CMPII Group"). CMP and CMPII may be deemed to have voting, investment and dispositive power with respect to the securities held by the CMP Group and the CMPII Group, respectively. The reporting person is a managing member of both CMP and CMPII. Thus, the reporting person may be deemed to share voting, investment and dispositive power with respect to the shares of Common Stock held by CMP and the CMP Group and CMPII and the CMPII Group. F10 · ownership.nature: Additionally, the reporting person, as the trustee of the Trust, has the sole voting and disposition power in connection with the Common Stock held of record by the Trust. The reporting person disclaims beneficial ownership of the securities discussed herein and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interests therein. Read SEC document |
| January 22, 2021 Filed Jan 26, 2021 18:44 UTC | Accolade, Inc. ACCD · Entity 80959 | OtherCommon Stock | 2,075,349 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-21-000070 · form4.xml · nonDerivative · entry 4 Madden James C. · CIK 0001408228 · Fomer Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,211,213 F3 · shares: On January 22, 2021, 2,075,349 shares of the Common Stock held of record by Carrick Capital Partners, L.P. ("CCP") were distributed to the fund's respective partners, on a pro rata basis, for no consideration. CCP no longer holds any shares of Common Stock. On the same date, 20,491 of CCP's shares of Common Stock were transferred to CMP, CCP's general partner. F3 · price: On January 22, 2021, 2,075,349 shares of the Common Stock held of record by Carrick Capital Partners, L.P. ("CCP") were distributed to the fund's respective partners, on a pro rata basis, for no consideration. CCP no longer holds any shares of Common Stock. On the same date, 20,491 of CCP's shares of Common Stock were transferred to CMP, CCP's general partner. F9 · ownership.nature: CMP is the general partner of each of CCAF, CCFF and CCP (the "CMP Group"). CMPII is the general partner of each of CIF and CIFII (the "CMPII Group"). CMP and CMPII may be deemed to have voting, investment and dispositive power with respect to the securities held by the CMP Group and the CMPII Group, respectively. The reporting person is a managing member of both CMP and CMPII. Thus, the reporting person may be deemed to share voting, investment and dispositive power with respect to the shares of Common Stock held by CMP and the CMP Group and CMPII and the CMPII Group. F10 · ownership.nature: Additionally, the reporting person, as the trustee of the Trust, has the sole voting and disposition power in connection with the Common Stock held of record by the Trust. The reporting person disclaims beneficial ownership of the securities discussed herein and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interests therein. Read SEC document |
| January 22, 2021 Filed Jan 26, 2021 18:44 UTC | Accolade, Inc. ACCD · Entity 80959 | OtherCommon Stock | 6,682 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-21-000070 · form4.xml · nonDerivative · entry 3 Madden James C. · CIK 0001408228 · Fomer Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 3,286,562 F2 · shares: On January 22, 2021, 6,682 shares of the Common Stock held of record by Carrick Capital Founders Fund, L.P. ("CCFF") were distributed to the fund's respective partners for no consideration. CCFF continued to hold 109,878 shares of Common Stock. F2 · price: On January 22, 2021, 6,682 shares of the Common Stock held of record by Carrick Capital Founders Fund, L.P. ("CCFF") were distributed to the fund's respective partners for no consideration. CCFF continued to hold 109,878 shares of Common Stock. F9 · ownership.nature: CMP is the general partner of each of CCAF, CCFF and CCP (the "CMP Group"). CMPII is the general partner of each of CIF and CIFII (the "CMPII Group"). CMP and CMPII may be deemed to have voting, investment and dispositive power with respect to the securities held by the CMP Group and the CMPII Group, respectively. The reporting person is a managing member of both CMP and CMPII. Thus, the reporting person may be deemed to share voting, investment and dispositive power with respect to the shares of Common Stock held by CMP and the CMP Group and CMPII and the CMPII Group. F10 · ownership.nature: Additionally, the reporting person, as the trustee of the Trust, has the sole voting and disposition power in connection with the Common Stock held of record by the Trust. The reporting person disclaims beneficial ownership of the securities discussed herein and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interests therein. Read SEC document |
| January 22, 2021 Filed Jan 26, 2021 18:44 UTC | Accolade, Inc. ACCD · Entity 80959 | OtherCommon Stock | 3,401 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-21-000070 · form4.xml · nonDerivative · entry 2 Madden James C. · CIK 0001408228 · Fomer Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 3,293,244 F1 · shares: On January 22, 2021, 341,153 shares of the common stock of Accolade, Inc. (the "Common Stock") held of record by Carrick Capital Associates Fund, L.P. ("CCAF") were distributed to the fund's respective partners for no consideration. CCAF no longer holds any shares of Common Stock. On the same date, 3,401 of CCAF's shares of Common Stock were transferred to Carrick Management Partners, LLC ("CMP"), CCAF's general partner. F1 · price: On January 22, 2021, 341,153 shares of the common stock of Accolade, Inc. (the "Common Stock") held of record by Carrick Capital Associates Fund, L.P. ("CCAF") were distributed to the fund's respective partners for no consideration. CCAF no longer holds any shares of Common Stock. On the same date, 3,401 of CCAF's shares of Common Stock were transferred to Carrick Management Partners, LLC ("CMP"), CCAF's general partner. F9 · ownership.nature: CMP is the general partner of each of CCAF, CCFF and CCP (the "CMP Group"). CMPII is the general partner of each of CIF and CIFII (the "CMPII Group"). CMP and CMPII may be deemed to have voting, investment and dispositive power with respect to the securities held by the CMP Group and the CMPII Group, respectively. The reporting person is a managing member of both CMP and CMPII. Thus, the reporting person may be deemed to share voting, investment and dispositive power with respect to the shares of Common Stock held by CMP and the CMP Group and CMPII and the CMPII Group. F10 · ownership.nature: Additionally, the reporting person, as the trustee of the Trust, has the sole voting and disposition power in connection with the Common Stock held of record by the Trust. The reporting person disclaims beneficial ownership of the securities discussed herein and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interests therein. Read SEC document |
| January 22, 2021 Filed Jan 26, 2021 18:44 UTC | Accolade, Inc. ACCD · Entity 80959 | OtherCommon Stock | 341,153 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-21-000070 · form4.xml · nonDerivative · entry 1 Madden James C. · CIK 0001408228 · Fomer Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 3,289,843 F1 · shares: On January 22, 2021, 341,153 shares of the common stock of Accolade, Inc. (the "Common Stock") held of record by Carrick Capital Associates Fund, L.P. ("CCAF") were distributed to the fund's respective partners for no consideration. CCAF no longer holds any shares of Common Stock. On the same date, 3,401 of CCAF's shares of Common Stock were transferred to Carrick Management Partners, LLC ("CMP"), CCAF's general partner. F1 · price: On January 22, 2021, 341,153 shares of the common stock of Accolade, Inc. (the "Common Stock") held of record by Carrick Capital Associates Fund, L.P. ("CCAF") were distributed to the fund's respective partners for no consideration. CCAF no longer holds any shares of Common Stock. On the same date, 3,401 of CCAF's shares of Common Stock were transferred to Carrick Management Partners, LLC ("CMP"), CCAF's general partner. F9 · ownership.nature: CMP is the general partner of each of CCAF, CCFF and CCP (the "CMP Group"). CMPII is the general partner of each of CIF and CIFII (the "CMPII Group"). CMP and CMPII may be deemed to have voting, investment and dispositive power with respect to the securities held by the CMP Group and the CMPII Group, respectively. The reporting person is a managing member of both CMP and CMPII. Thus, the reporting person may be deemed to share voting, investment and dispositive power with respect to the shares of Common Stock held by CMP and the CMP Group and CMPII and the CMPII Group. F10 · ownership.nature: Additionally, the reporting person, as the trustee of the Trust, has the sole voting and disposition power in connection with the Common Stock held of record by the Trust. The reporting person disclaims beneficial ownership of the securities discussed herein and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interests therein. Read SEC document |
| July 07, 2020 Filed Jul 8, 2020 18:57 UTC | Accolade, Inc. ACCD · Entity 80959 | ConversionWarrants · Derivative | 101,600 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-20-000645 · form4.xml · derivative · entry 6 Madden James C. · CIK 0001408228 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · Not disclosed shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: Prior to the IPO, CIF and CIFII each held fully-vested warrants, which would have expired on March 16, 2028, for the purchase of up to 50,800 shares of Common Stock. Upon the closing of the IPO, the warrants were automatically net exercised and surrendered such that the holder of each warrant received 50,798 of shares of Common Stock based on the IPO Price and after deduction of the exercise price, which was $0.0005 per share. No fractional shares were issued as a result of this warrant exercise. F8 · price: Prior to the IPO, CIF and CIFII each held fully-vested warrants, which would have expired on March 16, 2028, for the purchase of up to 50,800 shares of Common Stock. Upon the closing of the IPO, the warrants were automatically net exercised and surrendered such that the holder of each warrant received 50,798 of shares of Common Stock based on the IPO Price and after deduction of the exercise price, which was $0.0005 per share. No fractional shares were issued as a result of this warrant exercise. F8 · derivative.exercise_date: Prior to the IPO, CIF and CIFII each held fully-vested warrants, which would have expired on March 16, 2028, for the purchase of up to 50,800 shares of Common Stock. Upon the closing of the IPO, the warrants were automatically net exercised and surrendered such that the holder of each warrant received 50,798 of shares of Common Stock based on the IPO Price and after deduction of the exercise price, which was $0.0005 per share. No fractional shares were issued as a result of this warrant exercise. F8 · derivative.expiration_date: Prior to the IPO, CIF and CIFII each held fully-vested warrants, which would have expired on March 16, 2028, for the purchase of up to 50,800 shares of Common Stock. Upon the closing of the IPO, the warrants were automatically net exercised and surrendered such that the holder of each warrant received 50,798 of shares of Common Stock based on the IPO Price and after deduction of the exercise price, which was $0.0005 per share. No fractional shares were issued as a result of this warrant exercise. F8 · derivative.underlying_shares: Prior to the IPO, CIF and CIFII each held fully-vested warrants, which would have expired on March 16, 2028, for the purchase of up to 50,800 shares of Common Stock. Upon the closing of the IPO, the warrants were automatically net exercised and surrendered such that the holder of each warrant received 50,798 of shares of Common Stock based on the IPO Price and after deduction of the exercise price, which was $0.0005 per share. No fractional shares were issued as a result of this warrant exercise. F3 · ownership.nature: The reporting person is a member of the Issuer's board of directors and is a managing member of both CMP and CMPII. The reporting person may be deemed to share voting, investment and dispositive power with respect to the shares of Common Stock held by the CMP Group and the CMPII Group. The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interests therein. Read SEC document |
| July 07, 2020 Filed Jul 8, 2020 18:57 UTC | Accolade, Inc. ACCD · Entity 80959 | ConversionSeries E Preferred Stock · Derivative | 419,076 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-20-000645 · form4.xml · derivative · entry 5 Madden James C. · CIK 0001408228 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · Not disclosed shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: Effective upon the closing of the IPO, each share of the Issuer's Series E Preferred Stock (the "Series E Preferred") held by the CMPII Group automatically converted into approximately 2.0846 shares of Common Stock. No fractional shares were issued as a result of this conversion. Prior to the IPO, the Series E Preferred was convertible at any time into shares of Common Stock at the then-effective conversion rate for no additional consideration in accordance with the Charter and had no expiration date. F7 · price: Effective upon the closing of the IPO, each share of the Issuer's Series E Preferred Stock (the "Series E Preferred") held by the CMPII Group automatically converted into approximately 2.0846 shares of Common Stock. No fractional shares were issued as a result of this conversion. Prior to the IPO, the Series E Preferred was convertible at any time into shares of Common Stock at the then-effective conversion rate for no additional consideration in accordance with the Charter and had no expiration date. F7 · derivative.exercise_date: Effective upon the closing of the IPO, each share of the Issuer's Series E Preferred Stock (the "Series E Preferred") held by the CMPII Group automatically converted into approximately 2.0846 shares of Common Stock. No fractional shares were issued as a result of this conversion. Prior to the IPO, the Series E Preferred was convertible at any time into shares of Common Stock at the then-effective conversion rate for no additional consideration in accordance with the Charter and had no expiration date. F7 · derivative.expiration_date: Effective upon the closing of the IPO, each share of the Issuer's Series E Preferred Stock (the "Series E Preferred") held by the CMPII Group automatically converted into approximately 2.0846 shares of Common Stock. No fractional shares were issued as a result of this conversion. Prior to the IPO, the Series E Preferred was convertible at any time into shares of Common Stock at the then-effective conversion rate for no additional consideration in accordance with the Charter and had no expiration date. F7 · derivative.underlying_shares: Effective upon the closing of the IPO, each share of the Issuer's Series E Preferred Stock (the "Series E Preferred") held by the CMPII Group automatically converted into approximately 2.0846 shares of Common Stock. No fractional shares were issued as a result of this conversion. Prior to the IPO, the Series E Preferred was convertible at any time into shares of Common Stock at the then-effective conversion rate for no additional consideration in accordance with the Charter and had no expiration date. F3 · ownership.nature: The reporting person is a member of the Issuer's board of directors and is a managing member of both CMP and CMPII. The reporting person may be deemed to share voting, investment and dispositive power with respect to the shares of Common Stock held by the CMP Group and the CMPII Group. The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interests therein. Read SEC document |
| July 07, 2020 Filed Jul 8, 2020 18:57 UTC | Accolade, Inc. ACCD · Entity 80959 | ConversionSeries D Preferred Stock · Derivative | 1,424,360 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-20-000645 · form4.xml · derivative · entry 4 Madden James C. · CIK 0001408228 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · Not disclosed shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Effective upon the closing of the IPO, each share of the Issuer's Series D Preferred Stock (the "Series D Preferred") held by the CMP Group automatically converted into approximately 1.7784 shares of Common Stock. No fractional shares were issued as a result of this conversion. Prior to the IPO, the Series D Preferred was convertible at any time into shares of Common Stock at the then-effective conversion rate for no additional consideration in accordance with the Charter and had no expiration date. F6 · price: Effective upon the closing of the IPO, each share of the Issuer's Series D Preferred Stock (the "Series D Preferred") held by the CMP Group automatically converted into approximately 1.7784 shares of Common Stock. No fractional shares were issued as a result of this conversion. Prior to the IPO, the Series D Preferred was convertible at any time into shares of Common Stock at the then-effective conversion rate for no additional consideration in accordance with the Charter and had no expiration date. F6 · derivative.exercise_date: Effective upon the closing of the IPO, each share of the Issuer's Series D Preferred Stock (the "Series D Preferred") held by the CMP Group automatically converted into approximately 1.7784 shares of Common Stock. No fractional shares were issued as a result of this conversion. Prior to the IPO, the Series D Preferred was convertible at any time into shares of Common Stock at the then-effective conversion rate for no additional consideration in accordance with the Charter and had no expiration date. F6 · derivative.expiration_date: Effective upon the closing of the IPO, each share of the Issuer's Series D Preferred Stock (the "Series D Preferred") held by the CMP Group automatically converted into approximately 1.7784 shares of Common Stock. No fractional shares were issued as a result of this conversion. Prior to the IPO, the Series D Preferred was convertible at any time into shares of Common Stock at the then-effective conversion rate for no additional consideration in accordance with the Charter and had no expiration date. F6 · derivative.underlying_shares: Effective upon the closing of the IPO, each share of the Issuer's Series D Preferred Stock (the "Series D Preferred") held by the CMP Group automatically converted into approximately 1.7784 shares of Common Stock. No fractional shares were issued as a result of this conversion. Prior to the IPO, the Series D Preferred was convertible at any time into shares of Common Stock at the then-effective conversion rate for no additional consideration in accordance with the Charter and had no expiration date. F3 · ownership.nature: The reporting person is a member of the Issuer's board of directors and is a managing member of both CMP and CMPII. The reporting person may be deemed to share voting, investment and dispositive power with respect to the shares of Common Stock held by the CMP Group and the CMPII Group. The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interests therein. Read SEC document |
| July 07, 2020 Filed Jul 8, 2020 18:57 UTC | Accolade, Inc. ACCD · Entity 80959 | ConversionSeries C Preferred Stock · Derivative | 4,784 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-20-000645 · form4.xml · derivative · entry 3 Madden James C. · CIK 0001408228 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By James C. Madden V. Living Trust Disclosed balance after: 0 Underlying: Common Stock · Not disclosed shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Effective upon the closing of the IPO, each share of the Issuer's Series C Preferred Stock (the "Series C Preferred") held by the Trust automatically converted into approximately 1.5293 shares of Common Stock. No fractional shares were issued as a result of this conversion. Prior to the IPO, the Series C Preferred was convertible at any time into shares of Common Stock at the then-effective conversion rate for no additional consideration in accordance with the Charter and had no expiration date. F5 · price: Effective upon the closing of the IPO, each share of the Issuer's Series C Preferred Stock (the "Series C Preferred") held by the Trust automatically converted into approximately 1.5293 shares of Common Stock. No fractional shares were issued as a result of this conversion. Prior to the IPO, the Series C Preferred was convertible at any time into shares of Common Stock at the then-effective conversion rate for no additional consideration in accordance with the Charter and had no expiration date. F5 · derivative.exercise_date: Effective upon the closing of the IPO, each share of the Issuer's Series C Preferred Stock (the "Series C Preferred") held by the Trust automatically converted into approximately 1.5293 shares of Common Stock. No fractional shares were issued as a result of this conversion. Prior to the IPO, the Series C Preferred was convertible at any time into shares of Common Stock at the then-effective conversion rate for no additional consideration in accordance with the Charter and had no expiration date. F5 · derivative.expiration_date: Effective upon the closing of the IPO, each share of the Issuer's Series C Preferred Stock (the "Series C Preferred") held by the Trust automatically converted into approximately 1.5293 shares of Common Stock. No fractional shares were issued as a result of this conversion. Prior to the IPO, the Series C Preferred was convertible at any time into shares of Common Stock at the then-effective conversion rate for no additional consideration in accordance with the Charter and had no expiration date. F5 · derivative.underlying_shares: Effective upon the closing of the IPO, each share of the Issuer's Series C Preferred Stock (the "Series C Preferred") held by the Trust automatically converted into approximately 1.5293 shares of Common Stock. No fractional shares were issued as a result of this conversion. Prior to the IPO, the Series C Preferred was convertible at any time into shares of Common Stock at the then-effective conversion rate for no additional consideration in accordance with the Charter and had no expiration date. F5 · ownership.nature: Effective upon the closing of the IPO, each share of the Issuer's Series C Preferred Stock (the "Series C Preferred") held by the Trust automatically converted into approximately 1.5293 shares of Common Stock. No fractional shares were issued as a result of this conversion. Prior to the IPO, the Series C Preferred was convertible at any time into shares of Common Stock at the then-effective conversion rate for no additional consideration in accordance with the Charter and had no expiration date. Read SEC document |
| July 07, 2020 Filed Jul 8, 2020 18:57 UTC | Accolade, Inc. ACCD · Entity 80959 | ConversionSeries B Preferred Stock · Derivative | 12,946 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-20-000645 · form4.xml · derivative · entry 2 Madden James C. · CIK 0001408228 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By James C. Madden V. Living Trust Disclosed balance after: 0 Underlying: Common Stock · Not disclosed shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Effective upon the closing of the Issuer's initial public offering (the "IPO"), each share of the Issuer's Series B Preferred Stock (the "Series B Preferred") held by the Trust automatically converted into approximately 1.1898 shares of Common Stock. No fractional shares were issued as a result of this conversion. Prior to the IPO, the Series B Preferred was convertible at any time into shares of Common Stock at the then-effective conversion rate for no additional consideration in accordance with the Issuer's Seventh Amended and Restated Certificate of Incorporation, as amended to date (the "Charter") and had no expiration date. F4 · price: Effective upon the closing of the Issuer's initial public offering (the "IPO"), each share of the Issuer's Series B Preferred Stock (the "Series B Preferred") held by the Trust automatically converted into approximately 1.1898 shares of Common Stock. No fractional shares were issued as a result of this conversion. Prior to the IPO, the Series B Preferred was convertible at any time into shares of Common Stock at the then-effective conversion rate for no additional consideration in accordance with the Issuer's Seventh Amended and Restated Certificate of Incorporation, as amended to date (the "Charter") and had no expiration date. F4 · derivative.exercise_date: Effective upon the closing of the Issuer's initial public offering (the "IPO"), each share of the Issuer's Series B Preferred Stock (the "Series B Preferred") held by the Trust automatically converted into approximately 1.1898 shares of Common Stock. No fractional shares were issued as a result of this conversion. Prior to the IPO, the Series B Preferred was convertible at any time into shares of Common Stock at the then-effective conversion rate for no additional consideration in accordance with the Issuer's Seventh Amended and Restated Certificate of Incorporation, as amended to date (the "Charter") and had no expiration date. F4 · derivative.expiration_date: Effective upon the closing of the Issuer's initial public offering (the "IPO"), each share of the Issuer's Series B Preferred Stock (the "Series B Preferred") held by the Trust automatically converted into approximately 1.1898 shares of Common Stock. No fractional shares were issued as a result of this conversion. Prior to the IPO, the Series B Preferred was convertible at any time into shares of Common Stock at the then-effective conversion rate for no additional consideration in accordance with the Issuer's Seventh Amended and Restated Certificate of Incorporation, as amended to date (the "Charter") and had no expiration date. F4 · derivative.underlying_shares: Effective upon the closing of the Issuer's initial public offering (the "IPO"), each share of the Issuer's Series B Preferred Stock (the "Series B Preferred") held by the Trust automatically converted into approximately 1.1898 shares of Common Stock. No fractional shares were issued as a result of this conversion. Prior to the IPO, the Series B Preferred was convertible at any time into shares of Common Stock at the then-effective conversion rate for no additional consideration in accordance with the Issuer's Seventh Amended and Restated Certificate of Incorporation, as amended to date (the "Charter") and had no expiration date. F4 · ownership.nature: Effective upon the closing of the Issuer's initial public offering (the "IPO"), each share of the Issuer's Series B Preferred Stock (the "Series B Preferred") held by the Trust automatically converted into approximately 1.1898 shares of Common Stock. No fractional shares were issued as a result of this conversion. Prior to the IPO, the Series B Preferred was convertible at any time into shares of Common Stock at the then-effective conversion rate for no additional consideration in accordance with the Issuer's Seventh Amended and Restated Certificate of Incorporation, as amended to date (the "Charter") and had no expiration date. Read SEC document |
| July 07, 2020 Filed Jul 8, 2020 18:57 UTC | Accolade, Inc. ACCD · Entity 80959 | ConversionCommon Stock | 3,530,996 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-20-000645 · form4.xml · nonDerivative · entry 1 Madden James C. · CIK 0001408228 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 3,630,996 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The shares of the Issuer's Common Stock ("Common Stock") are held of record as follows: (i) 122,718 shares held of record by the James C Madden V. Living Trust (the "Trust") of which the reporting person is the trustee, (ii) 341,153 shares held of record by Carrick Capital Associates Fund, L.P. ("CCAF"), (iii) 116,560 shares held of record by Carrick Capital Founders Fund, L.P. ("CCFF"), (iv) 2,075,349 shares held of record by Carrick Capital Partners, L.P. ("CCP"), (v) 487,608 shares held of record by Carrick Capital Partners II Co-Investment Fund, L.P. ("CIF") and (vi) 487,608 shares held of record by Carrick Capital Partners II Co-Investment Fund II, L.P. ("CIFII"). F4 · price: Effective upon the closing of the Issuer's initial public offering (the "IPO"), each share of the Issuer's Series B Preferred Stock (the "Series B Preferred") held by the Trust automatically converted into approximately 1.1898 shares of Common Stock. No fractional shares were issued as a result of this conversion. Prior to the IPO, the Series B Preferred was convertible at any time into shares of Common Stock at the then-effective conversion rate for no additional consideration in accordance with the Issuer's Seventh Amended and Restated Certificate of Incorporation, as amended to date (the "Charter") and had no expiration date. F5 · price: Effective upon the closing of the IPO, each share of the Issuer's Series C Preferred Stock (the "Series C Preferred") held by the Trust automatically converted into approximately 1.5293 shares of Common Stock. No fractional shares were issued as a result of this conversion. Prior to the IPO, the Series C Preferred was convertible at any time into shares of Common Stock at the then-effective conversion rate for no additional consideration in accordance with the Charter and had no expiration date. F6 · price: Effective upon the closing of the IPO, each share of the Issuer's Series D Preferred Stock (the "Series D Preferred") held by the CMP Group automatically converted into approximately 1.7784 shares of Common Stock. No fractional shares were issued as a result of this conversion. Prior to the IPO, the Series D Preferred was convertible at any time into shares of Common Stock at the then-effective conversion rate for no additional consideration in accordance with the Charter and had no expiration date. F7 · price: Effective upon the closing of the IPO, each share of the Issuer's Series E Preferred Stock (the "Series E Preferred") held by the CMPII Group automatically converted into approximately 2.0846 shares of Common Stock. No fractional shares were issued as a result of this conversion. Prior to the IPO, the Series E Preferred was convertible at any time into shares of Common Stock at the then-effective conversion rate for no additional consideration in accordance with the Charter and had no expiration date. F8 · price: Prior to the IPO, CIF and CIFII each held fully-vested warrants, which would have expired on March 16, 2028, for the purchase of up to 50,800 shares of Common Stock. Upon the closing of the IPO, the warrants were automatically net exercised and surrendered such that the holder of each warrant received 50,798 of shares of Common Stock based on the IPO Price and after deduction of the exercise price, which was $0.0005 per share. No fractional shares were issued as a result of this warrant exercise. F1 · balance_after: The shares of the Issuer's Common Stock ("Common Stock") are held of record as follows: (i) 122,718 shares held of record by the James C Madden V. Living Trust (the "Trust") of which the reporting person is the trustee, (ii) 341,153 shares held of record by Carrick Capital Associates Fund, L.P. ("CCAF"), (iii) 116,560 shares held of record by Carrick Capital Founders Fund, L.P. ("CCFF"), (iv) 2,075,349 shares held of record by Carrick Capital Partners, L.P. ("CCP"), (v) 487,608 shares held of record by Carrick Capital Partners II Co-Investment Fund, L.P. ("CIF") and (vi) 487,608 shares held of record by Carrick Capital Partners II Co-Investment Fund II, L.P. ("CIFII"). F1 · ownership.nature: The shares of the Issuer's Common Stock ("Common Stock") are held of record as follows: (i) 122,718 shares held of record by the James C Madden V. Living Trust (the "Trust") of which the reporting person is the trustee, (ii) 341,153 shares held of record by Carrick Capital Associates Fund, L.P. ("CCAF"), (iii) 116,560 shares held of record by Carrick Capital Founders Fund, L.P. ("CCFF"), (iv) 2,075,349 shares held of record by Carrick Capital Partners, L.P. ("CCP"), (v) 487,608 shares held of record by Carrick Capital Partners II Co-Investment Fund, L.P. ("CIF") and (vi) 487,608 shares held of record by Carrick Capital Partners II Co-Investment Fund II, L.P. ("CIFII"). F2 · ownership.nature: Carrick Management Partners, LLC ("CMP" and, together with CCAF, CCFF and CCP, the "CMP Group") is the general partner of each of CCAF, CCFF and CCP. Carrick Management Partners II, LLC ("CMPII" and, together with CIF and CIFII, the "CMPII Group") is the general partner of each of CIF and CIFII. CMP and CMPII may be deemed to have voting, investment and dispositive power with respect to the securities held by the CMP Group and the CMPII Group, respectively. F3 · ownership.nature: The reporting person is a member of the Issuer's board of directors and is a managing member of both CMP and CMPII. The reporting person may be deemed to share voting, investment and dispositive power with respect to the shares of Common Stock held by the CMP Group and the CMPII Group. The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interests therein. Read SEC document |
| May 20, 2020 Filed May 22, 2020 20:06 UTC | Genpact LTD G · Entity 3760 | GrantCommon Shares | 8,617 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-20-010993 · doc1.xml · nonDerivative · entry 1 Madden James C. · CIK 0001408228 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,604 F1 · shares: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2020 and will be settled in common shares on December 31, 2021. Read SEC document |
| May 09, 2019 Filed May 13, 2019 20:19 UTC | Genpact LTD G · Entity 3760 | GrantCommon Shares | 3,326 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-010574 · doc1.xml · nonDerivative · entry 1 Madden James C. · CIK 0001408228 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,987 F1 · shares: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2019 and will be settled in common shares on December 31, 2020. Read SEC document |
| May 08, 2018 Filed May 10, 2018 20:27 UTC | Genpact LTD G · Entity 3760 | GrantCommon Shares | 3,961 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-022798 · doc1.xml · nonDerivative · entry 1 Madden James C. · CIK 0001408228 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,661 F1 · shares: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2018 and will be settled in common shares on December 31, 2019. Read SEC document |
| February 15, 2018 Filed Feb 16, 2018 21:03 UTC | Genpact LTD G · Entity 3760 | SaleCommon Shares | 4,270 | $30.92 | $132,036.09 |
DisclosureSEC source: 0001140361-18-008811 · doc1.xml · nonDerivative · entry 1 Madden James C. · CIK 0001408228 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,700 F1 · price: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $30.9201 to $30.922. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| May 12, 2017 Filed May 15, 2017 20:09 UTC | Genpact LTD G · Entity 3760 | SaleCommon Shares | 5,224 | $25.51 | $133,288.27 |
DisclosureSEC source: 0001140361-17-020653 · doc1.xml · nonDerivative · entry 1 Madden James C. · CIK 0001408228 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,970 F1 · price: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $25.41 to $25.59. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| May 09, 2017 Filed May 11, 2017 20:09 UTC | Genpact LTD G · Entity 3760 | GrantCommon Shares | 4,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-019745 · doc1.xml · nonDerivative · entry 1 Madden James C. · CIK 0001408228 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,194 F1 · shares: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2017 and will be settled in common shares on December 31, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.